This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peter Vollmers, H. Articles by Müller-Hermelink, H. K. Search for Related Content PubMed PubMed Citation Articles by Peter Vollmers, H. Articles by Müller-Hermelink, H. K.

SC-1, a Functional Human Monoclonal Antibody against Autologous Stomach Carcinoma Cells¹

Pathologisches Institut der Universität Würzburg, Josef-Schneider Str. 2, 8700 Würzburg, Federal Republic of Germany

Human monoclonal antibodies were isolated from stomach carcinoma patients by the fusion of spleen and lymph node lymphocytes with the heteromyeloma line SPM4-0. Initial screening was carried out on autologous primary tumor cell cultures in an adhesion assay in order to select surface-reactive functional antibodies. This was followed by live cell immunoperoxidase staining assays. The human monoclonal antibody SC-1 was found to selectively react with cultured cells isolated from autologous and allogeneic stomach carcinoma patients, and with cryostat sections of the primary tumors. More extensive screening revealed that the antibody showed no reactivity with a wide range of tumor tissues and normal cells. Some reactivity was present on fetal tissues. SC-1 inhibits movement of the autologous tumor cells and identifies a protein with a molecular weight of 50,000.

This study demonstrates that, with the use of selective screening assays on primary tumor material, it is possible to isolate antibodies which not only result from an immune response in the patient but also interfere with intercellular processes of tumor cells.

¹ This work was supported by Dr. Mildred-Scheel-Stiftung/Deutsche Krebshilfe e.V.

² To whom requests for reprints should be addressed.

Received 5/ 6/88. Revised 11/16/88. Accepted 1/26/89.

This article has been cited by other articles:

				S. Noisakran and G. C. Perng Alternate Hypothesis on the Pathogenesis of Dengue Hemorrhagic Fever (DHF)/Dengue Shock Syndrome (DSS) in Dengue Virus Infection Experimental Biology and Medicine, April 1, 2008; 233(4): 401 - 408. [Abstract] [Full Text] [PDF]

				P. Carter, L. Smith, and M. Ryan Identification and validation of cell surface antigens for antibody targeting in oncology Endocr. Relat. Cancer, December 1, 2004; 11(4): 659 - 687. [Abstract] [Full Text] [PDF]

				T. Pohle, S. Brandlein, N. Ruoff, H. K. Muller-Hermelink, and H. P. Vollmers Lipoptosis: Tumor-Specific Cell Death by Antibody-Induced Intracellular Lipid Accumulation Cancer Res., June 1, 2004; 64(11): 3900 - 3906. [Abstract] [Full Text] [PDF]

				S. Brandlein, T. Pohle, N. Ruoff, E. Wozniak, H.-K. Muller-Hermelink, and H. P. Vollmers Natural IgM Antibodies and Immunosurveillance Mechanisms against Epithelial Cancer Cells in Humans Cancer Res., November 15, 2003; 63(22): 7995 - 8005. [Abstract] [Full Text] [PDF]

				S. Brandlein, I. Beyer, M. Eck, W. Bernhardt, F. Hensel, H. K. Muller-Hermelink, and H. P. Vollmers Cysteine-rich Fibroblast Growth Factor Receptor 1, a New Marker for Precancerous Epithelial Lesions Defined by the Human Monoclonal Antibody PAM-1 Cancer Res., May 1, 2003; 63(9): 2052 - 2061. [Abstract] [Full Text] [PDF]

				F. Hensel, R. Hermann, C. Schubert, N. Abe, K. Schmidt, A. Franke, A. Shevchenko, M. Mann, H. K. Muller-Hermelink, and H. P. Vollmers Characterization of Glycosylphosphatidylinositol-linked Molecule CD55/Decay-accelerating Factor as the Receptor for Antibody SC-1-induced Apoptosis Cancer Res., October 1, 1999; 59(20): 5299 - 5306. [Abstract] [Full Text] [PDF]